Baird raised the firm’s price target on CVS Health (CVS) to $71 from $51 and keeps a Neutral rating on the shares. The firm sees minimal incremental buyers of stocks in the managed care and healthcare ...

Truist Financial analyst David S Macdonald maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...

Shares of pharmacy and insurance giant CVS Health (NYSE: CVS) were soaring 8.2% higher as of 11:32 a.m. ET on Tuesday. Part ...

CVS is shaking up its management ranks as newly installed CEO David Joyner tries to put his stamp on the health-care ...

In a year marked by macroeconomic uncertainty and renewed trade tensions that have shaken the equity market, CVS Health CVS has emerged as an unexpected outperformer. After a rough 2024, marked by ...

A better consumer experience has implications for clinical improvements, according to a new report from CVS Health. | A ...

The board of CVS Health Corporation ( NYSE:CVS ) has announced that it will pay a dividend of $0.665 per share on ...

CVS Health Corp. continues to fight a civil lawsuit that accuses the corporation and its retail pharmacists of wrongfully ...

CVS Health's chief financial officer, Thomas Cowhey, intends to step down, Bloomberg News reported on Monday, amid the health ...

Analysts have recently evaluated CVS Health and provided 12-month price targets. The average target is $74.12, accompanied by ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

A House committee stripped the provision that made PBM executives sweat, but Senate Bill 140 still has some meat.